Online citations, reference lists, and bibliographies.
← Back to Search

Homing Of Liposomes To Target Cells.

G. Gregoriadis
Published 1975 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Summary The possibility of homing liposomes to target cells was investigated. Liposomes containing an antitumour drug and associated with molecular probes which exhibit a specific affinity for the surface of a variety of normal and malignant cells were prepared. In vitro and in vivo experiments suggested that such probes were capable of mediating selective cellular uptake of the associated liposomes and the entrapped drug. It is anticipated that liposomes designed to home may become important tools in the control of cell behaviour.
This paper references
10.1042/BJ1400323
Comparative effect and fate of non-entrapped and liposome-entrapped neuraminidase injected into rats.
G. Gregoriadis (1974)
10.1016/S0006-291X(75)80433-5
The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs.
R. Juliano (1975)
10.1111/j.1749-6632.1964.tb14213.x
DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS *
B. J. Davis (1964)
10.1083/JCB.63.2.492
THE INTERACTION OF CATIONIC LIPOSOMES CONTAINING ENTRAPPED HORSERADISH PEROXIDASE WITH CELLS IN CULTURE
W. Magee (1974)
10.1016/0014-5793(74)80813-6
Entrapment of proteins in liposomes prevents allergic reactions in pre‐immunised mice
G. Gregoriadis (1974)
10.1083/JCB.65.1.112
Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal
Y. E. Rahman (1975)
10.1007/978-3-642-81049-7_8
Liposomes as immunological adjuvants
A. Allison (1974)
10.1038/182053A0
Efficient Trace-labelling of Proteins with Iodine
A. McFarlane (1958)
10.1016/0006-291X(72)90310-5
A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes.
S. Hickman (1972)
10.1016/0076-6879(63)06207-8
The thiobarbituric acid assay of sialic acids.
L. Warren (1959)
10.1016/S0140-6736(74)90682-5
Drug-carrier potential of liposomes in cancer chemotherapy.
G. Gregoriadis (1974)
10.1016/0014-5793(73)80394-1
Drug entrapment in liposomes
G. Gregoriadis (1973)
10.1016/0076-6879(71)22017-6
[15] Isolation of plasma membranes from mammalian cells
E. H. Eylar (1971)
10.1016/s0021-9258(19)52451-6
Protein measurement with the Folin phenol reagent.
O. H. Lowry (1951)
10.1016/0005-2736(71)90181-7
Phospholipid-protein interactions: membrane permeability correlated with monolayer "penetration".
H. Kimelberg (1971)
10.1016/s0021-9258(19)76994-4
The role of sialic acid in determining the survival of glycoproteins in the circulation.
A. Morell (1971)
10.1111/J.1432-1033.1974.TB03681.X
Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications.
G. Gregoriadis (1974)
10.1016/S0021-9673(01)85372-3
Use of simple concentration gradients for the fractionation of human serum proteins on DEAE-cellulose, with especial reference to the isolation of albumin, prealbumin, haemopexin and transferrin.
D. Ramsden (1973)
10.1016/s0021-9258(18)62728-0
Catabolism of desialylated ceruloplasmin in the liver.
G. Gregoriadis (1970)



This paper is referenced by
10.1007/BF00834903
Enhancing specificity and stability of targeted liposomes by coincorporation of sialoglycoprotein and antibody on liposomes
B. Khaw (2004)
10.1007/978-1-4684-7275-2_11
Experimental Aspects of Antiviral Pharmacology
W. Prusoff (1988)
10.3109/10731199409138854
Double-tailed perfluoroalkylated glycolipids as components for drug delivery and targeting systems. Preliminary biocompatibility results.
L. Zarif (1994)
10.1007/978-1-4684-4862-7_14
Fate of Liposomes In Vivo: Control Leading to Targeting
G. Gregoriadis (1984)
10.1007/978-1-4899-0127-9_4
Long Circulating Liposomes: Evolution of the Concept
G. Gregoriadis (1998)
10.1002/JPS.2600710403
Experimental methods in cancer therapeutics.
K. Widder (1982)
10.1038/288602A0
Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A
L. Leserman (1980)
10.1007/978-1-4615-9071-2_70
Enzyme therapy XI: immunologic considerations for replacement therapy with unentrapped, erythrocyte- and liposome-entrapped enzymes.
R. Desnick (1978)
10.1016/0024-3205(77)90481-7
Liposomes as drug carriers.
J. H. Fendler (1977)
10.1016/S0091-679X(08)60468-9
Lipid vesicles as carriers for introducing biologically active materials into cells.
G. Poste (1976)
10.1111/j.1749-6632.1978.tb22038.x
PHARMACOKINETICS OF LIPOSOME‐ENCAPSULATED ANTITUMOR DRUGS AND IMPLICATIONS FOR THERAPY *
R. Juliano (1978)
10.1111/j.1749-6632.1993.tb17237.x
mAb‐Labeled Liposomes in Breast Cancer Cell Targeting
G. Rombi (1993)
10.1016/0141-0229(81)90003-X
Immobilization of proteins on liposome surface
V. Torchilin (1981)
10.1016/0163-7258(80)90010-8
Targeting of drugs: possibilities in viral chemotherapy and prophylaxis.
G. Gregoriadis (1980)
10.1016/S1369-7021(05)71033-6
Targeted for drug delivery
T. Fahmy (2005)
10.1111/j.1749-6632.1978.tb22025.x
LIPOSOMES AS LYSOSOMOTROPIC CARRIERS
Christian de Duve (1978)
10.1016/0006-291X(78)90640-X
Comparative studies on covalent and noncovalent immobilization of protein molecules on the surface of liposomes.
V. Torchilin (1978)
10.1016/0304-4165(76)90136-7
The use of a liposomally entrapped enzyme in the treatment of an artificial storage condition.
C. Colley (1976)
10.1016/S0014-4827(77)80022-0
Interaction of liposomes with polymorphonuclear leukocytes. I. Studies on the mode of interaction.
O. Stendahl (1977)
10.1111/J.1432-1033.1982.TB05812.X
Expression of two late adenovirus genes is altered by introducing antibodies against ribonucleoprotein into living HeLa cells.
R. Lenk (1982)
10.1007/978-3-642-75862-1_8
In Vivo Behavior of Liposomes: Interactions with the Mononuclear Phagocyte System and Implications for Drug Targeting
G. Scherphof (1991)
10.1080/1061186021000054924
Temperature sensitive liposomes of plumbagin: characterization and in vivo evaluation in mice bearing melanoma B16F1.
S. Tiwari (2002)
10.1002/wnan.106
Nanoimaging and neurological surgery.
Ion Dan Grosu (2010)
10.1016/S0006-291X(88)81333-0
Liposome targeting to mouse brain: mannose as a recognition marker.
F. Umezawa (1988)
10.1016/S0923-2494(92)80161-D
Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages.
G. Gregoriadis (1992)
10.1016/B978-0-08-023180-8.50013-5
INTRODUCTION OF ENZYMES INTO LIVER CELLS BY MEANS OF LIPOSOMES
F. H. Roerdink (1979)
10.1016/0014-5793(80)80639-9
Selective inhibition of ectromelia virus DNA synthesis in hepatocytes by adenine‐9‐β‐D‐arabinofuranoside (ara‐A) and adenine‐9‐β‐D‐arabinofuranoside 5′‐monophosphate (ara‐AMP) conjugated to asialofetuin
L. Fiume (1980)
10.1201/9780203485651.CH4
Development of New Drugs by Research Institutes and the Pharmaceutical Industry
Chi-Jen Lee (2003)
10.1007/BF00746082
Mab labelled liposomes as selective vehicles for drugs in H.I.V. infected cells
G. P. Rombi (1993)
Inhibitionof Tumor Cell Growthin Vitro and in Vivoby 1-@3.D- Arabinofuranosylcytosine EntrappedwithinPhospholipidVesicles1
E. Mayhew (1976)
10.1083/JCB.70.3.494
Lipid vesicle-cell interactions. I. Hemagglutination and hemolysis
F. Martín (1976)
10.1016/0161-5890(81)90033-X
Interactions of gamma-immunoglobulins with lipid mono- or bilayers and liposomes. Existence of two conformations of gamma-immunoglobulins of different hydrophobicities.
M. Vandenbranden (1981)
See more
Semantic Scholar Logo Some data provided by SemanticScholar